DEF 14A

Company

Milestone Pharmaceuticals Inc.

Filed

May 2, 2022

Period of Report

July 5, 2022

Accession Number

0001104659-22-054778

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →